Virtual clinical trials (VCT) are in-silico reproductions of medical examinations, which adopt digital models ofpatients and simulated devices. They are intended to produce clinically equivalent outcome data avoiding long execution times, ethical issues related to radiation induced risks and huge costs related to real clinical trials with a patient population. In this work, we present a platform for VCT in 2D and 3D X-ray breast imaging. The VCT platform uses Monte Carlo simulations based on the Geant4 toolkit and patient breast models derived from a cohort of high resolution dedicated breast CT (BCT) volume data sets. Projection images of the breast and three-dimensional glandular dose maps are generated for a given breast model, by simulating both 2D full-field digital mammography (DM) and 3D BCT examinations. Uncompressed voxelized breast models were derived from segmented patient images. Compressed versions of the digital breast phantoms for DM were generated using apreviously published digital compression algorithm. The Monte Carlo simulation framework has the capability of generating and tracking ~10^5 photons/s using a server equipped with 16-cores and 3.0 GHz clock speed. The VCT platform will provide a framework for scanner design optimization, comparison between different scanner designs and between different modalities or protocols on computational breast models, without the need for scanning actual patients as in conventional clinical trials.

GEANT4 Monte Carlo simulations for virtual clinical trials in breast X-ray imaging: Proof of concept / di Franco, F.; Sarno, A.; Mettivier, G.; Hernandez, A. M.; Bliznakova, K.; Boone, J. M.; Russo, P.. - In: PHYSICA MEDICA. - ISSN 1120-1797. - 74:(2020), pp. 133-142. [10.1016/j.ejmp.2020.05.007]

GEANT4 Monte Carlo simulations for virtual clinical trials in breast X-ray imaging: Proof of concept

Sarno, A.;Mettivier, G.;Russo, P.
2020

Abstract

Virtual clinical trials (VCT) are in-silico reproductions of medical examinations, which adopt digital models ofpatients and simulated devices. They are intended to produce clinically equivalent outcome data avoiding long execution times, ethical issues related to radiation induced risks and huge costs related to real clinical trials with a patient population. In this work, we present a platform for VCT in 2D and 3D X-ray breast imaging. The VCT platform uses Monte Carlo simulations based on the Geant4 toolkit and patient breast models derived from a cohort of high resolution dedicated breast CT (BCT) volume data sets. Projection images of the breast and three-dimensional glandular dose maps are generated for a given breast model, by simulating both 2D full-field digital mammography (DM) and 3D BCT examinations. Uncompressed voxelized breast models were derived from segmented patient images. Compressed versions of the digital breast phantoms for DM were generated using apreviously published digital compression algorithm. The Monte Carlo simulation framework has the capability of generating and tracking ~10^5 photons/s using a server equipped with 16-cores and 3.0 GHz clock speed. The VCT platform will provide a framework for scanner design optimization, comparison between different scanner designs and between different modalities or protocols on computational breast models, without the need for scanning actual patients as in conventional clinical trials.
2020
GEANT4 Monte Carlo simulations for virtual clinical trials in breast X-ray imaging: Proof of concept / di Franco, F.; Sarno, A.; Mettivier, G.; Hernandez, A. M.; Bliznakova, K.; Boone, J. M.; Russo, P.. - In: PHYSICA MEDICA. - ISSN 1120-1797. - 74:(2020), pp. 133-142. [10.1016/j.ejmp.2020.05.007]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/806957
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 25
  • ???jsp.display-item.citation.isi??? 23
social impact